[1] 樊建勇, 赵阳, 杨慧兰. 单纯疱疹病毒的潜伏、复发感染与防治[J]. 中国医学文摘: 皮肤科学, 2017, 34(1):9-17. [2] Johnston C, Corey L.Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract[J]. Clin Microbiol Rev, 2016, 29(1):149-161. [3] Meyding-Lamadé U, Strank C.Herpes virus infections of the central nervous system in immunocompromised patients[J]. Ther Adv Neurol Disord, 2012, 5(5):279-296. [4] Looker KJ, Maqaret AS, Turner KM, et al.Correction: Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012[J]. PLoS One, 2015, 10(1): e114989. [5] Tronstein E, Johnston C, Huang ML, et al.Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection[J]. JAMA, 2011,305(14):1441-1449. [6] Freeman EE, WEISS HA, Glynn JR, et al.Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies[J]. AIDS, 2006, 20(1):73-83. [7] 杨荷丹, 蒋娟. 单纯疱疹病毒感染的复发机制与治疗的研究进展[J]. 中国麻风皮肤病杂志, 2018, 34(11):694-697. [8] Nicoll MP, Proenca JT, Efstathiou S.The molecular basis of herpes simplex virus latency[J]. FEMS Microbiol Rev, 2012, 36(3):684-705. [9] Efstathiou S, Preston CM.Towards an understanding of the molecular basis of herpes simplex virus latency[J]. Virus Res, 2005, 111(2):108-119. [10] 候亚林, 杜立行, 欧柏生, 等. 参芪止疱颗粒抗HSV-2的体外实验研究[J]. 陕西中医, 2018, 39(1):10-13. [11] Parr MB, Parr EL.Protective immunity against HSV-2 in the mouse vagina[J]. J Reprod Immunol, 1997, 36(1-2):77-92. [12] Parr MB, Parr EL.Vaginal immunity in the HSV-2 mouse model[J]. Int Rev Immunol, 2003, 22:43-63. [13] McDermott MR, Smiley JR, Leslie P, et al. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2[J]. J Virol, 1984, 51(3):747-753. [14] Lo M, Zhu J, Hanson SG, et al.Acute infection and subsequent subclinical reactivation of herpes simplex virus-2 after vaginal inoculation of rhesus macaques[J]. J Virol, 2019, 93(2):e01574-18. [15] Bernstein DI, Cardin RD, Pullum DA, et al.Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials[J]. PLoS One, 2019, 14(3):e0213401. [16] Awasthi S, Hook LM, Shaw CE, et al.An HSV-2 trivalent vaccine is immunogenic in rhesus macaques and highly efficacious in guinea pigs[J]. PLoS Pathog, 2017, 13(1): e1006141. [17] 杜丽芳, 张晓焕, 高华, 等. 检测Ⅱ型单纯疱疹病毒DNA拷贝的real-time qPCR方法的建立及其应用[J]. 中国生物制品学杂志, 2016, 29(10):1082-1086. [18] Burrel S, Boutolleau D, Ryu D, et al.Ancient Recombination Events between Human Herpes Simplex Viruses[J]. Mol Biol Evol, 2017, 34(7):1713-1721. [19] 陈平, 马良, 刘二战, 等.不同人群感染单纯疱疹病毒2型的流行病学特点[J]. 国际生物制品学杂志, 2015, 38(4):189-192. [20] Awasthi S, Mahairas GG, Shaw CE, et al.A dual-modality Herpes simplex virus 2 vaccine for preventing genital herpes by using glycoprotein C and D subunit antigens to induce potent antibody responses and adenovirus vectors containing capsid and tegument proteins as T Cell immunogens[J]. J Virol, 2015, 89(16):8497-8509. [21] 范胜涛, 冯敏, 徐兴丽, 等. 1型单纯疱疹病毒经不同途径感染小鼠建立病理模型的比较分析[J]. 中国生物制品学杂志, 2017, 5(5):472-476. |